Nov 23, 2021

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in genitourinary cancers. Featuring perspectives from Drs Neeraj Agarwal and Daniel Petrylak, including the following topics:

• Introduction
• Case: A woman in her early 50s with metastatic renal cell carcinoma with rhabdoid features — Dr Kumar
• Comparing First-Line Treatment Options for Metastatic Renal Cell Carcinoma Chalk Talk — Dr Petrylak
• Second-Line Treatment of Metastatic Renal Cell Carcinoma After Progression on Checkpoint Inhibitor-Based Therapy Chalk Talk — Dr Agarwal
• Case: A healthy man in his late 80s with locally recurrent castration-resistant prostate cancer (CRPC) — Dr Guancial
• Case: A man in his mid-80s with metastatic CRPC and a somatic BRCA2 mutation — Dr Zafar
• 177Lu-PSMA-617 in Metastatic CRPC Chalk Talk — Dr Agarwal
• Case: A man in his early 60s with metastatic CRPC and an ATM mutation — Dr Shameem
• Genomic Testing and PARP Inhibition for Metastatic Prostate Cancers with a BRCA Mutation Chalk Talk — Dr Petrylak
• Case: A woman in her late 70s with non-muscle-invasive urothelial bladder cancer — Dr Gandhi
• Case: A man in his late 60s with localized urothelial bladder carcinoma (UBC) — Dr Choksi
• Case: A woman in her early 70s with high-TMB muscle-invasive UBC and high-PD-L1 expression — Dr Guancial
• Genomic Testing and PARP Inhibition for Metastatic Prostate Cancers with a BRCA Mutation Chalk Talk — Dr Petrylak
• Sequencing Enfortumab Vedotin and Other Targeted Therapies for Metastatic UBC Chalk Talk — Dr Agarwal

CME information and select publications